CNBC's Becky Quick to Moderate CEO Leadership Dialogue on the Next Decade of Rare Disease at the NORD Breakthrough Summit

ConferenceNeutral

AI Analysis

Summary

BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs will participate in a CEO leadership dialogue at the NORD Breakthrough Summit moderated by CNBC's Becky Quick to discuss rare disease advancement and patient progress.

Importance:2/10

Sentiment:

0.00

Rare DiseaseConferenceIndustry LeadershipNORD Breakthrough Summit

Related Companies

$BMRN $JAZZ $OTSKF $NHPAP

Read the original article

Published by PR Newswire Pharma on October 6, 2026 8:31 PM

Read Original